BIOTECH
BIOTECH
Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)
Paris, France, January 22, 2026 – PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing...
Read more
BIOTECH
ErVimmune raises €17 million in Series A first closing to enter clinical development with lead cancer vaccine candidate
Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman....
Read more
BIOTECH
KAHR Bio Announces Strong Topline Phase 2 Results for DSP107 in Combination with Anti-PD-L1 Therapy in Colorectal Cancer
Phase 2 data demonstrated 17.5-month median overall survival in advanced, chemo-refractory patients with microsatellite stable...
Read more
BIOTECH
Lattice Medical raises €43 million to transform post-cancer reconstruction
Lille, France, October 23, 2025 – LATTICE MEDICAL, a French Medtech company specializing in tissue...
Read more
BIOTECH
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) — TREOS Bio Ltd., a clinical-stage biotechnology company developing...
Read more